Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis.

Sundstrøm T, Prestegarden L, Azuaje F, Aasen SN, Røsland GV, Varughese JK, Bahador M, Bernatz S, Braun Y, Harter PN, Skaftnesmo KO, Ingham ES, Mahakian LM, Tam S, Tepper CG, Petersen K, Ferrara KW, Tronstad KJ, Lund-Johansen M, Beschorner R, Bjerkvig R, Thorsen F.

Acta Neuropathol Commun. 2019 Apr 10;7(1):55. doi: 10.1186/s40478-019-0712-8.

2.

Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide.

Johannessen TC, Hasan-Olive MM, Zhu H, Denisova O, Grudic A, Latif MA, Saed H, Varughese JK, Røsland GV, Yang N, Sundstrøm T, Nordal A, Tronstad KJ, Wang J, Lund-Johansen M, Simonsen A, Janji B, Westermarck J, Bjerkvig R, Prestegarden L.

Int J Cancer. 2019 Apr 1;144(7):1735-1745. doi: 10.1002/ijc.31912. Epub 2018 Dec 11.

PMID:
30289977
3.

Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy.

Wang J, Qi Q, Zhou W, Feng Z, Huang B, Chen A, Zhang D, Li W, Zhang Q, Jiang Z, Bjerkvig R, Prestegarden L, Thorsen F, Wang X, Li X, Wang J.

Autophagy. 2018;14(11):2007-2022. doi: 10.1080/15548627.2018.1501133. Epub 2018 Aug 17.

PMID:
30025493
4.

Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination.

Zhang X, Xu R, Zhang C, Xu Y, Han M, Huang B, Chen A, Qiu C, Thorsen F, Prestegarden L, Bjerkvig R, Wang J, Li X.

J Exp Clin Cancer Res. 2017 Sep 5;36(1):118. doi: 10.1186/s13046-017-0588-z.

5.

Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway.

Wang J, Qi Q, Feng Z, Zhang X, Huang B, Chen A, Prestegarden L, Li X, Wang J.

Oncotarget. 2016 Oct 11;7(41):66944-66958. doi: 10.18632/oncotarget.11396.

6.

Identification of a novel lytic peptide for the treatment of solid tumours.

Szczepanski C, Tenstad O, Baumann A, Martinez A, Myklebust R, Bjerkvig R, Prestegarden L.

Genes Cancer. 2014 May;5(5-6):186-200.

7.

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.

Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO, Sakariassen PØ, Eskilsson E, Stieber D, Keunen O, Brekka N, Moen I, Nigro JM, Vintermyr OK, Lund-Johansen M, Niclou S, Mørk SJ, Enger PO, Bjerkvig R, Miletic H.

Acta Neuropathol. 2013 May;125(5):683-98. doi: 10.1007/s00401-013-1101-1. Epub 2013 Feb 22.

8.

The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.

Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R.

Neuro Oncol. 2013 Mar;15(3):269-78. doi: 10.1093/neuonc/nos301. Epub 2012 Dec 20.

9.

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.

Svendsen A, Verhoeff JJ, Immervoll H, Brøgger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planagumà J, Torsvik A, Kjersem AB, Sakariassen PØ, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PØ, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M.

Acta Neuropathol. 2011 Oct;122(4):495-510. doi: 10.1007/s00401-011-0867-2. Epub 2011 Aug 24.

10.

Cancer stem cells in the central nervous system--a critical review.

Prestegarden L, Enger PØ.

Cancer Res. 2010 Nov 1;70(21):8255-8. doi: 10.1158/0008-5472.CAN-10-1592. Epub 2010 Oct 19. Review.

11.

Glioma cell populations grouped by different cell type markers drive brain tumor growth.

Prestegarden L, Svendsen A, Wang J, Sleire L, Skaftnesmo KO, Bjerkvig R, Yan T, Askland L, Persson A, Sakariassen PØ, Enger PØ.

Cancer Res. 2010 Jun 1;70(11):4274-9. doi: 10.1158/0008-5472.CAN-09-3904. Epub 2010 May 11.

12.

Amplifying small amounts of tumor DNA allows detection of DNA copy number abberations with array-CGH.

Prestegarden L, Misra A, Ware ML, Yeh RF, Bjerkvig R, Feuerstein BG.

Biotechniques. 2008 Jun;44(7):Piii-Pvi. doi: 10.2144/000112760.

13.

MicroRNAs in tumorigenesis.

Skaftnesmo KO, Prestegarden L, Micklem DR, Lorens JB.

Curr Pharm Biotechnol. 2007 Dec;8(6):320-5. Review.

PMID:
18289039
14.

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.

Wang J, Sakariassen PØ, Tsinkalovsky O, Immervoll H, Bøe SO, Svendsen A, Prestegarden L, Røsland G, Thorsen F, Stuhr L, Molven A, Bjerkvig R, Enger PØ.

Int J Cancer. 2008 Feb 15;122(4):761-8.

15.

Angiogenesis-independent tumor growth mediated by stem-like cancer cells.

Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PØ.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16466-71. Epub 2006 Oct 20.

16.

Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation.

Sundlisaeter E, Wang J, Sakariassen PØ, Marie M, Mathisen JR, Karlsen BO, Prestegarden L, Skaftnesmo KO, Bjerkvig R, Enger PØ.

Neuropathol Appl Neurobiol. 2006 Aug;32(4):419-27.

PMID:
16866987

Supplemental Content

Loading ...
Support Center